ATOPE+: An mHealth System to Support Personalized Therapeutic Exercise Interventions in Patients With Cancer
MetadataShow full item record
AuthorMoreno Gutiérrez, Salvador; Postigo Martín, Elisa Paula; Damas Hermoso, Miguel; Pomares Cintas, Héctor Emilio; Baños Legrán, Oresti; Arroyo Morales, Manuel; Cantarero Villanueva, Irene
S. Moreno-Gutierrez et al., "ATOPE+: An mHealth System to Support Personalized Therapeutic Exercise Interventions in Patients With Cancer," in IEEE Access, vol. 9, pp. 16878-16898, 2021, [10.1109/ACCESS.2021.3049398]
SponsorshipSpanish Ministry of Science, Innovation, and Universities (MICINN) PGC2018-098813-B-C31 RTI2018-101674-B-I00; Health Research Funds of the Carlos III Health Institute PI18/01840; German Research Foundation (DFG) FPU16/04201 FPU17/00939
The introduction of mobile technologies in therapeutic exercise interventions has permitted the collection of fine-grained objective quantified information about patients' health. However, exercise interventions generally fail to leverage these data when personalizing the exercise needs of patients individually. Interventions that include technology-driven personalization strategies typically rely on the use of expensive laboratory equipment with expert supervision, or in the self-management of patients to meet the prescribed exercise levels by an activity tracker. These methods often do not perform better than non technology-driven methods, therefore more sophisticated strategies are required to improve the personalization process. In this paper we present ATOPE+, an mHealth system to support personalized exercise interventions in patients with cancer based on workload-recovery ratio estimation. ATOPE+ enables the remote assessment of workload-recovery ratio to provide optimal exercise dosage by means of a knowledge-based system and by combining physiological data from heterogeneous data sources in a multilevel architecture. The results show that ATOPE+ is a system ready to be used in the context of a clinical trial after being tested with patients with breast cancer and conducting an usability evaluation by clinical experts.